BioAge Looks To Tackle Diseases Of Aging, Starting With Muscle Loss
Existing Cash Will Fund First Phase II Trial
Emerging Company Profile: BioAge has Phase Ib proof-of-concept data in age-related muscle loss and is gearing up for its first Phase II study, but will need fresh cash or a partner for a potential weight loss-related muscle loss study.
